Awareness on Super Bugs & Antibiotics

Despite some hospitals routinely changing which antibiotics they use and others prescribing alternative drugs, " first-rate-bugs" continue to emerge. As Ainsworth (2001) argues, "Although at that place was a 45-fold decrease in the use of sulphonamide antibiotics between 1991 and 1999, in that respect was no reduction in the level of resistance in bacterium" (1).

Using drugs to fighting insects and pathogens in livestock has also increased the rapid mutation of "super-bugs." Antibiotics, according to Weisberg (2003) be " supply unnecessarily to healthy livestock, poultry and fish to promote moderately faster growth and to compensate for unsanitary conditions" (25). Human beings stimulate susceptible because galore(postnominal) antibiotics used on livestock are used on humans, making them ineffective against already kind strains of bacteria. Because of the enormous costs of create antibiotics that will attack "super-bugs" efficaciously and because of the lower amount of such drugs needed by patients, some argue that pharmaceutical companies are not even developing new drugs to focus on "super-bugs." As Nelson (2003) contends, "Just as super bugs are becoming a greater threat, many pharmaceutical companies are curtailing their antibacterial research and development programs, and, in some case, pulling out of

The health community and researchers are in a draw with such "super-bugs", before their numbers become a monolithic overt health concern. During the anthrax attacks the shortage of antibiotics was highlighted. During major bacterial outbreaks, the health community must rely on dear(predicate) antibiotics like Vancomycin, Methicillin, and Zyvox.

The resistance of "super-bugs" to more inexpensive antibiotics costs the united States between $30 billion and %50 billion to combat them on an annual basis, according to biologist Steve Palumbi (Stenger 2001). Cost of treating just one infection is much higher because of the resistant bacteria. galore(postnominal) argue that the U.S. health, research, and government approach to fighting resistant bacteria is part of the problem. Instead of a pro-active approach, Stenger (2001) maintains, "The present approach to combating super mutants is all defense and no offense: Wait for a new strain to emerge and then devise a new drug or pesticide to fight it" (1).

Will argent save us from the super-bugs? (May/Jun 1995). The Wholistic News Magazine, 42(18), 18-19.

Nelson, R. (Nov 22, 2003). Antibiotic development personal credit line runs dry. Lancet, 362(9397), 1726-1727.

Weisberg, K. (Jan 15, 2003). Fight super bugs. FoodService Director, 16(1), 25-26.

The advent of "super-bugs" poses a major public health threat to the U.S. and countries around the world. Some hospitals switch antib
Ordercustompaper.com is a professional essay writing service at which you can buy essays on any topics and disciplines! All custom essays are written by professional writers!